The Safety and Effectiveness of Retrovir in HIV-Infected Patients Who Have Problems Related to the Nervous System
To assess the efficacy of Retrovir (AZT) therapy in the treatment of HIV Ab positive persons with impairments in neuropsychological functioning. To assess the safety, virologic, and immunologic effects of AZT therapy in HIV Ab positive persons with neuropsychological impairment but minimal other symptomatology.
|Study Design:||Primary Purpose: Treatment|
|Official Title:||Safety and Efficacy of Retrovir in HIV Infected Patients Having Neuropsychological Impairments|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00002288
|United States, North Carolina|
|Glaxo Wellcome Inc|
|Research Triangle Park, North Carolina, United States, 27709|